Currency exchange rates have fluctuated considerably in the last few years, adding to the volatility generic competition brings to drugmakers' revenue. ...
In the patent protected portfolio in line products like Lipitor, Lyrica, Chantix, Geodon, Xalatan and Zyvox continued to perform well, both internationally ...
Generic competition hurt the blood pressure treatment Norvasc (amlodipine), which fell 10% to $486 million, while sales of the smoking cessation drug ...
Email this story